Valneva SE (VALN)
NASDAQ: VALN
· Real-Time Price · USD
6.10
-0.18 (-2.87%)
At close: Jun 06, 2025, 2:10 PM
-2.87% (1D)
| Bid | 6.01 |
| Market Cap | 518.69M |
| Revenue (ttm) | 186.06M |
| Net Income (ttm) | -80.39M |
| EPS (ttm) | -1.27 |
| PE Ratio (ttm) | -4.8 |
| Forward PE | -10.42 |
| Analyst | Buy |
| Ask | 6.2 |
| Volume | 9,460 |
| Avg. Volume (20D) | 76,084 |
| Open | 6.15 |
| Previous Close | 6.28 |
| Day's Range | 6.00 - 6.19 |
| 52-Week Range | 3.62 - 8.99 |
| Beta | 1.10 |
About VALN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VALN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VALN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+12.08%
Valneva shares are trading higher after the Brazil...
Unlock content with
Pro Subscription
2 months ago
+3.63%
Valneva shares are trading higher after reaching an agreement with a local French public health agency to provide 40,000 doses of IXCHIQ.
4 weeks ago · seekingalpha.com
Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 GuidanceValneva SE offers exposure to a robust travel vaccine portfolio that includes Ixiaro, Dukoral, and Ixchiq. Ixiaro generated roughly €94.1 million in 2024 and remains Valneva's main revenue vertical. D...
